Kim, J J; Lee, Y A; Su, D; Lee, J; Park, S J; Kim, B; Lee, J H J; Liu, X; Kim, S S; Bae, M A; Lee, J S; Hong, S C; Wang, L; Samanta, A; Kwon, H Y; Choi, S Y; Kim, J Y; Yu, Y H; Ha, H H; Wang, Z; Tam, W L; Lim, B; Kang, N Y; Chang, Y T
(American Chemical Society, 2019-08-22)
Tumor initiating cells (TIC) are resistant to conventional anticancer therapy and associated with metastasis and relapse in cancer. Although various TIC markers and their antibodies have been proposed, it is limited to the ...